ESTABLISHMENT LABS HOLDINGS INC. — Form 8-K
Filed October 29, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 62/100
What the filing says
Establishment Labs reported Q3 2026 revenue of $72.0M (33.9% YoY growth), with U.S. revenue surging 119% to $26.0M and minimally invasive revenue up 124% to ~$9M. The company achieved its first positive operating cash flow quarter ($7.7M operating, $5.1M free cash flow) and raised full-year 2026 revenue guidance to >$274M from $269–$271M. Adjusted EBITDA improved to $6.4M (8.9% margin) from $1.2M; however, GAAP net loss remained at $10.7M, driven by $20.9M interest expense year-to-date on $267.8M debt (vs. $247.5M at year-end 2025). The company guided FY2027 to 25% growth and positive cash flow.
Why this rating
Strong organic growth (34% YoY revenue, 119% U.S. growth) and first FCF milestone are material relative to $975M market cap (~7.4% of FY guidance). However, heavy debt burden ($267.8M, 74% of assets) and persistent GAAP losses temper trajectory change.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.